世界の抗エイズ薬市場 2019年

【英語タイトル】Global Anti-AIDs Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料(DATA908B05404)・商品コード:DATA908B05404
・発行会社(調査会社):QYResearch
・発行日:2019年8月20日
・ページ数:101
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥367,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥735,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、抗エイズ薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、処方薬、非処方薬に、用途別には、薬局、病院にセグメント区分し、抗エイズ薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・抗エイズ薬の世界市場概要
・抗エイズ薬の製造コスト構成分析
・抗エイズ薬の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・抗エイズ薬の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・抗エイズ薬のセグメント分析(種類別)
(処方薬、非処方薬)
・抗エイズ薬のセグメント分析(用途別)
(薬局、病院)
・抗エイズ薬の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(GSK、Cipla、MSD、Gilead Sciences、Frontier Biotechnologies)
・抗エイズ薬の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

The global Anti-AIDs Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-AIDs Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-AIDs Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anti-AIDs Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anti-AIDs Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
GSK
Cipla
MSD
Gilead Sciences
Frontier Biotechnologies

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Prescription Drugs
Non-prescription Drugs

Segment by Application
Pharmacy
Hospital

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Anti-AIDs Drug
1.1 Definition of Anti-AIDs Drug
1.2 Anti-AIDs Drug Segment by Type
1.2.1 Global Anti-AIDs Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Prescription Drugs
1.2.3 Non-prescription Drugs
1.3 Anti-AIDs Drug Segment by Applications
1.3.1 Global Anti-AIDs Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Pharmacy
1.3.3 Hospital
1.4 Global Anti-AIDs Drug Overall Market
1.4.1 Global Anti-AIDs Drug Revenue (2014-2025)
1.4.2 Global Anti-AIDs Drug Production (2014-2025)
1.4.3 North America Anti-AIDs Drug Status and Prospect (2014-2025)
1.4.4 Europe Anti-AIDs Drug Status and Prospect (2014-2025)
1.4.5 China Anti-AIDs Drug Status and Prospect (2014-2025)
1.4.6 Japan Anti-AIDs Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Anti-AIDs Drug Status and Prospect (2014-2025)
1.4.8 India Anti-AIDs Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Anti-AIDs Drug
2.3 Manufacturing Process Analysis of Anti-AIDs Drug
2.4 Industry Chain Structure of Anti-AIDs Drug

3 Development and Manufacturing Plants Analysis of Anti-AIDs Drug
3.1 Capacity and Commercial Production Date
3.2 Global Anti-AIDs Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Anti-AIDs Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Anti-AIDs Drug Production and Capacity Analysis
4.2 Anti-AIDs Drug Revenue Analysis
4.3 Anti-AIDs Drug Price Analysis
4.4 Market Concentration Degree

5 Anti-AIDs Drug Regional Market Analysis
5.1 Anti-AIDs Drug Production by Regions
5.1.1 Global Anti-AIDs Drug Production by Regions
5.1.2 Global Anti-AIDs Drug Revenue by Regions
5.2 Anti-AIDs Drug Consumption by Regions
5.3 North America Anti-AIDs Drug Market Analysis
5.3.1 North America Anti-AIDs Drug Production
5.3.2 North America Anti-AIDs Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Anti-AIDs Drug Import and Export
5.4 Europe Anti-AIDs Drug Market Analysis
5.4.1 Europe Anti-AIDs Drug Production
5.4.2 Europe Anti-AIDs Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Anti-AIDs Drug Import and Export
5.5 China Anti-AIDs Drug Market Analysis
5.5.1 China Anti-AIDs Drug Production
5.5.2 China Anti-AIDs Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Anti-AIDs Drug Import and Export
5.6 Japan Anti-AIDs Drug Market Analysis
5.6.1 Japan Anti-AIDs Drug Production
5.6.2 Japan Anti-AIDs Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Anti-AIDs Drug Import and Export
5.7 Southeast Asia Anti-AIDs Drug Market Analysis
5.7.1 Southeast Asia Anti-AIDs Drug Production
5.7.2 Southeast Asia Anti-AIDs Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Anti-AIDs Drug Import and Export
5.8 India Anti-AIDs Drug Market Analysis
5.8.1 India Anti-AIDs Drug Production
5.8.2 India Anti-AIDs Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Anti-AIDs Drug Import and Export

6 Anti-AIDs Drug Segment Market Analysis (by Type)
6.1 Global Anti-AIDs Drug Production by Type
6.2 Global Anti-AIDs Drug Revenue by Type
6.3 Anti-AIDs Drug Price by Type

7 Anti-AIDs Drug Segment Market Analysis (by Application)
7.1 Global Anti-AIDs Drug Consumption by Application
7.2 Global Anti-AIDs Drug Consumption Market Share by Application (2014-2019)

8 Anti-AIDs Drug Major Manufacturers Analysis
8.1 GSK
8.1.1 GSK Anti-AIDs Drug Production Sites and Area Served
8.1.2 GSK Product Introduction, Application and Specification
8.1.3 GSK Anti-AIDs Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Cipla
8.2.1 Cipla Anti-AIDs Drug Production Sites and Area Served
8.2.2 Cipla Product Introduction, Application and Specification
8.2.3 Cipla Anti-AIDs Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 MSD
8.3.1 MSD Anti-AIDs Drug Production Sites and Area Served
8.3.2 MSD Product Introduction, Application and Specification
8.3.3 MSD Anti-AIDs Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Gilead Sciences
8.4.1 Gilead Sciences Anti-AIDs Drug Production Sites and Area Served
8.4.2 Gilead Sciences Product Introduction, Application and Specification
8.4.3 Gilead Sciences Anti-AIDs Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Frontier Biotechnologies
8.5.1 Frontier Biotechnologies Anti-AIDs Drug Production Sites and Area Served
8.5.2 Frontier Biotechnologies Product Introduction, Application and Specification
8.5.3 Frontier Biotechnologies Anti-AIDs Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Anti-AIDs Drug Market
9.1 Global Anti-AIDs Drug Market Trend Analysis
9.1.1 Global Anti-AIDs Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Anti-AIDs Drug Regional Market Trend
9.2.1 North America Anti-AIDs Drug Forecast 2019-2025
9.2.2 Europe Anti-AIDs Drug Forecast 2019-2025
9.2.3 China Anti-AIDs Drug Forecast 2019-2025
9.2.4 Japan Anti-AIDs Drug Forecast 2019-2025
9.2.5 Southeast Asia Anti-AIDs Drug Forecast 2019-2025
9.2.6 India Anti-AIDs Drug Forecast 2019-2025
9.3 Anti-AIDs Drug Market Trend (Product Type)
9.4 Anti-AIDs Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Anti-AIDs Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Anti-AIDs Drug
Table Global Anti-AIDs Drug Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global Anti-AIDs Drug Production Market Share by Types in 2018
Figure Prescription Drugs Product Picture
Figure Non-prescription Drugs Product Picture
Table Global Anti-AIDs Drug Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global Anti-AIDs Drug Consumption Market Share by Applications in 2018
Figure Pharmacy
Figure Hospital
Figure Global Anti-AIDs Drug Revenue (Million USD) (2014-2025)
Figure Global Anti-AIDs Drug Production (K Doses) (2014-2025)
Figure North America Anti-AIDs Drug Market Size (Million USD) (2014-2025)
Figure Europe Anti-AIDs Drug Market Size (Million USD) (2014-2025)
Figure China Anti-AIDs Drug Market Size (Million USD) (2014-2025)
Figure Japan Anti-AIDs Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Anti-AIDs Drug Market Size (Million USD) (2014-2025)
Figure India Anti-AIDs Drug Market Size (Million USD) (2014-2025)
Table Anti-AIDs Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Anti-AIDs Drug in 2018
Figure Manufacturing Process Analysis of Anti-AIDs Drug
Figure Industry Chain Structure of Anti-AIDs Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Anti-AIDs Drug Manufacturing Plants Distribution
Table Anti-AIDs Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Anti-AIDs Drug Capacity (K Doses) of Major Manufacturers (2014-2019)
Table Anti-AIDs Drug Production (K Doses) of Major Manufacturers (2014-2019)
Table Anti-AIDs Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Anti-AIDs Drug Production Share by Manufacturers in 2018
Table Anti-AIDs Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Anti-AIDs Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Anti-AIDs Drug Revenue Share by Manufacturers in 2018
Table Anti-AIDs Drug Average Price (USD/Dose) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Anti-AIDs Drug Production by Regions 2014-2019 (K Doses)
Table Global Anti-AIDs Drug Production Market Share by Regions 2014-2019
Figure Global Anti-AIDs Drug Production Market Share by Regions in 2018
Table Global Anti-AIDs Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Anti-AIDs Drug Revenue Market Share by Regions 2014-2019
Figure Global Anti-AIDs Drug Revenue Market Share by Regions in 2018
Table Global Anti-AIDs Drug Consumption by Regions 2014-2019 (K Doses)
Table Global Anti-AIDs Drug Consumption Market Share by Regions 2014-2019
Figure North America Anti-AIDs Drug Production Growth Rate 2014-2019 (K Doses)
Figure North America Anti-AIDs Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Anti-AIDs Drug Production, Consumption Import and Export (K Doses)
Figure Europe Anti-AIDs Drug Production Growth Rate 2014-2019 (K Doses)
Figure Europe Anti-AIDs Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Anti-AIDs Drug Production, Consumption Import and Export (K Doses)
Figure China Anti-AIDs Drug Production Growth Rate 2014-2019 (K Doses)
Figure China Anti-AIDs Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Anti-AIDs Drug Production, Consumption Import and Export (K Doses)
Figure Japan Anti-AIDs Drug Production Growth Rate 2014-2019 (K Doses)
Figure Japan Anti-AIDs Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Anti-AIDs Drug Production, Consumption Import and Export (K Doses)
Figure Southeast Asia Anti-AIDs Drug Production Growth Rate 2014-2019 (K Doses)
Figure Southeast Asia Anti-AIDs Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Anti-AIDs Drug Production, Consumption Import and Export (K Doses)
Figure India Anti-AIDs Drug Production Growth Rate 2014-2019 (K Doses)
Figure India Anti-AIDs Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Anti-AIDs Drug Production, Consumption Import and Export (K Doses)
Figure Global Consumption Anti-AIDs Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Anti-AIDs Drug Market Share by Application (2014-2019)
Table GSK Anti-AIDs Drug Production Sites and Area Served
Table GSK Anti-AIDs Drug Product Introduction, Application and Specification
Table GSK Anti-AIDs Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table GSK Anti-AIDs Drug Production Growth Rate (2014-2019)
Table GSK Anti-AIDs Drug Production Market Share (2014-2019)
Figure GSK Anti-AIDs Drug Revenue Market Share (2014-2019)
Table GSK Anti-AIDs Drug Main Business and Markets Served
Table Cipla Anti-AIDs Drug Production Sites and Area Served
Table Cipla Anti-AIDs Drug Product Introduction, Application and Specification
Table Cipla Anti-AIDs Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Cipla Anti-AIDs Drug Production Growth Rate (2014-2019)
Table Cipla Anti-AIDs Drug Production Market Share (2014-2019)
Figure Cipla Anti-AIDs Drug Revenue Market Share (2014-2019)
Table Cipla Anti-AIDs Drug Main Business and Markets Served
Table MSD Anti-AIDs Drug Production Sites and Area Served
Table MSD Anti-AIDs Drug Product Introduction, Application and Specification
Table MSD Anti-AIDs Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table MSD Anti-AIDs Drug Production Growth Rate (2014-2019)
Table MSD Anti-AIDs Drug Production Market Share (2014-2019)
Figure MSD Anti-AIDs Drug Revenue Market Share (2014-2019)
Table MSD Anti-AIDs Drug Main Business and Markets Served
Table Gilead Sciences Anti-AIDs Drug Production Sites and Area Served
Table Gilead Sciences Anti-AIDs Drug Product Introduction, Application and Specification
Table Gilead Sciences Anti-AIDs Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Gilead Sciences Anti-AIDs Drug Production Growth Rate (2014-2019)
Table Gilead Sciences Anti-AIDs Drug Production Market Share (2014-2019)
Figure Gilead Sciences Anti-AIDs Drug Revenue Market Share (2014-2019)
Table Gilead Sciences Anti-AIDs Drug Main Business and Markets Served
Table Frontier Biotechnologies Anti-AIDs Drug Production Sites and Area Served
Table Frontier Biotechnologies Anti-AIDs Drug Product Introduction, Application and Specification
Table Frontier Biotechnologies Anti-AIDs Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Frontier Biotechnologies Anti-AIDs Drug Production Growth Rate (2014-2019)
Table Frontier Biotechnologies Anti-AIDs Drug Production Market Share (2014-2019)
Figure Frontier Biotechnologies Anti-AIDs Drug Revenue Market Share (2014-2019)
Table Frontier Biotechnologies Anti-AIDs Drug Main Business and Markets Served
Figure Global Anti-AIDs Drug Production (K Doses) Growth Rate Forecast 2019-2025
Figure Global Anti-AIDs Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Anti-AIDs Drug Sales Price (USD/Dose) Forecast 2019-2025
Figure North America Anti-AIDs Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure North America Anti-AIDs Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Anti-AIDs Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Europe Anti-AIDs Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Anti-AIDs Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure China Anti-AIDs Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Anti-AIDs Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Japan Anti-AIDs Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Anti-AIDs Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Southeast Asia Anti-AIDs Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Anti-AIDs Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure India Anti-AIDs Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Doses) of Anti-AIDs Drug by Type (2019-2025)
Table Global Consumption (K Doses) of Anti-AIDs Drug by Application (2019-2025)
Table Anti-AIDs Drug Distributors List
Table Anti-AIDs Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

GSK、Cipla、MSD、Gilead Sciences、Frontier Biotechnologies

★調査レポート[世界の抗エイズ薬市場 2019年] (コード:DATA908B05404)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗エイズ薬市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆